A Study of STX-1150 in Participants With Elevated Low-Density Lipoprotein Cholesterol (LDL-C)
A Study of STX-1150 in Participants With Elevated Low-Density Lipoprotein Cholesterol (LDL-C)
Recruiting · NCT07428473 · Registry updated 2026-09-21Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study of STX-1150 in Participants With Elevated Low-Density Lipoprotein Cholesterol (LDL-C) | Arterial Occlusive Diseases, Dyslipidemias, Hypercholesterolemia, Infarction, Lipid Metabolism Disorders, Necrosis, Nutritional and Metabolic Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, arteriosclerosis disorder, atherosclerosis, cardiovascular disorder, heart disorder, hyperlipidemia, hypertensive disorder, ischemic disease, metabolic disease, myocardial infarction, myocardial ischemia, vascular disorder | Recruiting | Phase 1 | 2026-09-21 | NCT07428473 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Monash University | 75 |
| Scribe Therapeutics Inc. | 1 |
3 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Aotearoa Clinical Trials/Middlemore Hospital | Papatoetoe | New Zealand | 1 |
| Monash Health/ Victorian Heart Hospital (VHH) | Clayton | Australia | 1 |
| New Zealand Clinical Research (NZCR) | Christchurch | New Zealand | 1 |